Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
- NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
- NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_assertion evidence source_evidence_literature NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
- NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_assertion SIO_000772 17962208 NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
- NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_assertion wasDerivedFrom befree-2016 NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
- NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_assertion wasGeneratedBy ECO_0000203 NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
- befree-2016 importedOn "2016-02-19" NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.